The short version
Most cash-pay GLP-1 programs land in the $178-$549/mo range at maintenance dose. The under-$150 tier is small but real, dominated by compounded oral semaglutide and the cheapest 503A pharmacy operators. The trade-off at this price tier: less clinical support, fewer dose options and (for the cheapest programs) higher regulatory exposure as state pharmacy boards tighten 503A oversight. Read the program-specific compounded-regulatory callouts before signing up.
What we considered
- All-in cash-pay monthly cost under $150 at maintenance dose
- No lock-in or aggressive minimum-commitment terms
- Public disclosure of the 503A compounding pharmacy
Top pick: Strut Health

Strut Health's compounded oral semaglutide at $149/mo flat is the most reliable under-$150 path. Oral format means no injections, which suits patients who are needle-averse. The pharmacy partner is disclosed.
Read the full Strut Health review →
Other strong picks
